Modern Diagnostic & Research Centre Schedules Board Meeting for Q2 Results
Modern Diagnostic & Research Centre Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 3:08 am
Modern Diagnostic & Research Centre Schedules Board Meeting for Q2 Results Modern Diagnostic & Research Centre Limited announced that its Board of Directors will meet on 14th Nov'26 to consider and approve the unaudited financial results, Statement of Assets & Liabilities, and Cash Flow Statement for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Modern Diagnostic & Research Centre Ltd
- Disclosure under Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 for the half year ended 30 September, 2026 路 17 Nov 2026
- Financial results along with statement of assets and liabilities for the half year ended 30.09.2026 路 15 Nov 2026
- In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting .... 路 14 Nov 2026
- Submission of voting results of the 14th AGM of Modern Diagnostic & Research Centre Limited held on Wednesday, 30th September, 2026 路 01 Oct 2026
- Outcome of Proceedings of AGM 路 30 Sept 2026
- Clarification on significant movement in the price of the securities of the company 路 15 Sept 2026
- The Exchange has sought clarification from Modern Diagnostic & Research Centre Ltd on September 15, 2026, with reference to Movement in Price.<BR><BR>The reply is awaited. 路 15 Sept 2026
- Pursuant to Regulations 29, 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the .... 路 05 Sept 2026
